Follow the 세종메디칼 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 세종메디칼 has logged 95 insider filings. The latest transaction was disclosed on 13 February 2026 (Other). Among the most active insiders: 비에스제이홀딩스. All data is free.
94
Insider Decl.
n/a
Thresholds
n/a
43 ops.
Buy Volume
n/a
6 ops.
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
세종메디칼 is a company specializing in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on the development and manufacturing of medical devices.